Priority Date: 17.11.11 (KR 20110120493)

ORAL COMPLEX FORMULATION COMPRISING OMEGA-3 FATTY ACID AND HMG-COA REDUCTASE INHIBITOR WITH IMPROVED STABILITY

  • Application ID: EP12850234
  • Status: EXAMINATION IN PROGRESS

Applicant

Technology company logo small
Technology Company

Attorney

Employment test 11 - 50 employees
Company dna von kreisler selting werner
operating since 1947
Headquarter in Cologne and 3 offices
active in Legal Services and IP Portfolio Processing

Specialization

This EP application has the IPC class A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE). dompatent von Kreisler Selting Werner - Partnerschaft von Patent- und Rechtsanwälten mbB is specialized in A61. Here you find a list of all patent agent firms which are specialized in this IPC class. For a similar patent, they might be a good choice.

Timeline

  • 17.11.2011 - Priority Date (KR 20110120493)
  • 23.05.2013 - Publication A1 (WO2013073884)
  • 24.09.2014 - Publication A1 (EP2780002)